Len Pattenden

Len Pattenden is an accomplished professional in the biopharmaceutical industry with extensive experience in various leadership roles. Currently serving as the Head of CMC at Fondazione Telethon, Len has previously held positions such as Managing Director at CMC Biopharma Ltd and Chief Operating Officer at Ascend Gene & Cell Therapies. Len also contributed significantly to Cancer Research UK as the Head of Biotherapeutic Development & Drug Supply and led the Vector Upstream Development Group at Adaptimmune. Len holds a Doctor of Philosophy (PhD) in Pharmaceutics and Drug Design from Queensland University of Technology, earned between 1997 and 2004.